— Nine more companies have joined President Donald Trump’s most-favorednation drug pricing agreement, one of the president’s most highly publicized affordability initiatives to bring down the cost of prescription drugs.
The president signed an executive order in May 2025 directing his administration to work toward securing most-favored-nation pricing with large pharmaceutical manufacturers. Most-fa…
